GEORGIA STATE UNIVERSITY IMAGE: DR. RICHARD PLEMPER, DIRECTOR OF THE CENTER FOR TRANSLATIONAL ANTIVIRAL RESEARCH AND DISTINGUISHED UNIVERSITY PROFESSOR IN THE INSTITUTE FOR BIOMEDICAL SCIENCES AT GEORGIA STATE UNIVERSITY CREDIT: GEORGIA STATE UNIVERSITY ATLANTA—SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for...